SCHEMBL18868545

SCHEMBL18868545

C=C(N)c1cccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27304431 0.80 — —
SCHEMBL565974 0.79 CES2 (0.64) —
SCHEMBL13656482 0.79 CES2 (0.56) —
SCHEMBL15818576 0.79 CES2 (0.56) —
SCHEMBL15818574 0.79 CES2 (0.56) —
SCHEMBL1379741 0.78 CES2 (0.56) —
SCHEMBL11773483 0.78 NOS1 (0.47) —
SCHEMBL5873384 0.77 CES2 (0.61) —
SCHEMBL4196929 0.77 CES2 (0.61) —
SCHEMBL14082103 0.77 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2496230-B1 IRE-1 ALPHA INHIBITORS FOSUN ORINOVE PHARMATECH INC (CN) 2020-02-26 — — EP disclosed
US-9761803-B2 Semiconductor composition XEROX CORPORATION (US) 2017-09-12 — — US disclosed
EP-3167886-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF MACULAR EDEMA SARcode Bioscience Inc. (US) 2017-05-17 — — EP disclosed
Send feedback